| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044099172 |
| P356 | DOI | 10.1038/ONC.2010.233 |
| P8608 | Fatcat ID | release_b4d6hlfsqzf2pa6zxn5knv2kem |
| P698 | PubMed publication ID | 20603620 |
| P5875 | ResearchGate publication ID | 45094653 |
| P50 | author | J Saadi Imam | Q52581225 |
| P2093 | author name string | Y Chen | |
| K Buddavarapu | |||
| M K Rao | |||
| S Ganapathy | |||
| C Camosy | |||
| J S Lee-Chang | |||
| P2860 | cites work | The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1 | Q24564859 |
| Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis | Q24644884 | ||
| Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition | Q24685187 | ||
| Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis | Q28185761 | ||
| The role of Six1 in mammalian auditory system development | Q28188638 | ||
| Six1 is required for the early organogenesis of mammalian kidney | Q28510085 | ||
| Six1 controls patterning of the mouse otic vesicle | Q28589213 | ||
| Six1 and Six4 homeoproteins are required for Pax3 and Mrf expression during myogenesis in the mouse embryo | Q28593548 | ||
| Neutral red uptake assay for the estimation of cell viability/cytotoxicity | Q30047632 | ||
| Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer | Q33860352 | ||
| Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy. | Q34390964 | ||
| The role of microRNAs in normal and malignant hematopoiesis | Q35002076 | ||
| TRAIL and apoptosis induction by TNF-family death receptors. | Q35591708 | ||
| Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma | Q36612365 | ||
| Defining a role for the homeoprotein Six1 in EMT and mammary tumorigenesis | Q37328411 | ||
| Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition | Q37328450 | ||
| The tumorigenicity diversification in human embryonic kidney 293 cell line cultured in vitro | Q39996786 | ||
| Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. | Q40149403 | ||
| Gene amplification is a mechanism of Six1 overexpression in breast cancer | Q40439862 | ||
| Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators | Q40602477 | ||
| Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation | Q42814954 | ||
| Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice | Q43860748 | ||
| Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil | Q45064015 | ||
| The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. | Q53349168 | ||
| P433 | issue | 35 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 4971-4979 | |
| P577 | publication date | 2010-07-05 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers | |
| P478 | volume | 29 |
| Q31133163 | A Bayesian integrative approach for multi-platform genomic data: A kidney cancer case study |
| Q52562647 | A step-by-step microRNA guide to cancer development and metastasis. |
| Q90163704 | Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma |
| Q30425832 | Androgen-responsive microRNAs in mouse Sertoli cells. |
| Q38268088 | Antisense therapeutics in oncology: current status |
| Q35310856 | Autoregulatory suppression of c-Myc by miR-185-3p |
| Q38559338 | Biomarkers to detect Wilms tumors in pediatric patients: where are we now? |
| Q38500323 | Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes |
| Q92787282 | Circular RNA circNHSL1 promotes gastric cancer progression through the miR-1306-3p/SIX1/vimentin axis |
| Q31009969 | DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs |
| Q39273744 | Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumor. |
| Q55115788 | Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines. |
| Q54322646 | Elevated microRNA-185 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in clear cell renal cell carcinoma. |
| Q36216208 | Epigenetic effects of selenium and their implications for health |
| Q36557328 | Exposure to airborne PM2.5 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells |
| Q38868233 | Expression of somatostatin receptor subtype 2 in growth hormone-secreting pituitary adenoma and the regulation of miR-185. |
| Q34533814 | Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization |
| Q38206779 | Homeobox Gene Deregulation: Impact on the Hallmarks of Cancer |
| Q34737713 | Hormone-induced and DNA demethylation-induced relief of a tissue-specific and developmentally regulated block in transcriptional elongation. |
| Q59798393 | Huayu Tongmai Granules protects against vascular endothelial dysfunction via up-regulating miR-185 and down-regulating RAGE |
| Q39762235 | Human cancer classification: a systems biology- based model integrating morphology, cancer stem cells, proteomics, and genomics |
| Q35082591 | Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies |
| Q39051113 | Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake |
| Q33684857 | Increased Six1 expression is associated with poor prognosis in patients with osteosarcoma |
| Q37100069 | Inhibition of FoxM1-Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and Metastasis |
| Q64964690 | Joint testing and false discovery rate control in high-dimensional multivariate regression. |
| Q99212569 | LncRNA-ROR/microRNA-185-3p/YAP1 axis exerts function in biological characteristics of osteosarcoma cells |
| Q55399851 | MiR-1180-5p regulates apoptosis of Wilms' tumor by targeting p73. |
| Q39210882 | MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine |
| Q42799144 | MiR-185 inhibits 3T3-L1 cell differentiation by targeting SREBP-1. |
| Q39472499 | MiR-384 regulated IRS1 expression and suppressed cell proliferation of human hepatocellular carcinoma |
| Q33598225 | MicroRNA-146a affects the chemotherapeutic sensitivity and prognosis of advanced gastric cancer through the regulation of LIN52 |
| Q37726121 | MicroRNA-185 regulates chemotherapeutic sensitivity in gastric cancer by targeting apoptosis repressor with caspase recruitment domain |
| Q39192939 | MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor |
| Q35057752 | MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes |
| Q39766103 | MicroRNA-185-5p mediates regulation of SREBP2 expression by hepatitis C virus core protein |
| Q33613370 | MicroRNA-30a regulates zebrafish myogenesis through targeting the transcription factor Six1 |
| Q38815056 | MicroRNA: a connecting road between apoptosis and cholesterol metabolism |
| Q34696427 | MicroRNAs and their applications in kidney diseases |
| Q34042888 | MicroRNAs associated with metastatic prostate cancer |
| Q39333266 | MicroRNAs in gynecological cancers: Small molecules with big implications |
| Q38118222 | MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis. |
| Q38133419 | MicroRNAs: potential regulators of renal development genes that contribute to CAKUT. |
| Q37792874 | MicroRNAs: tiny targets for engineering CHO cell phenotypes? |
| Q35135678 | Minireview: The roles of small RNA pathways in reproductive medicine |
| Q39429443 | Mutual enrichment in aggregated ranked lists with applications to gene expression regulation |
| Q37837735 | New players in ovarian cancer |
| Q60958994 | Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication |
| Q35853714 | On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics |
| Q89852415 | Overexpression of microRNA-185 alleviates intervertebral disc degeneration through inactivation of the Wnt/β-catenin signaling pathway and downregulation of Galectin-3 |
| Q37291394 | Potentials of the elevated circulating miR-185 level as a biomarker for early diagnosis of HBV-related liver fibrosis |
| Q33889489 | Regulation of cancer aggressive features in melanoma cells by microRNAs |
| Q36985088 | Repression of ATR pathway by miR-185 enhances radiation-induced apoptosis and proliferation inhibition |
| Q38230205 | Restoring TRAIL mediated signaling in ovarian cancer cells. |
| Q98771139 | Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned? |
| Q92542107 | SIX1 Activates STAT3 Signaling to Promote the Proliferation of Thyroid Carcinoma via EYA1 |
| Q36059882 | STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer |
| Q33597712 | Six1 expression is associated with a poor prognosis in patients with glioma |
| Q34634833 | Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression |
| Q38184513 | Six1: a critical transcription factor in tumorigenesis |
| Q35854054 | TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185 |
| Q38058733 | Targeting microRNAs to modulate TRAIL-induced apoptosis of cancer cells |
| Q54964308 | The Role of MicroRNAs in Kidney Disease. |
| Q35107900 | The SIX1-EYA transcriptional complex as a therapeutic target in cancer |
| Q36367578 | The impact of microRNA expression on cellular proliferation |
| Q26747218 | The retinal determination gene network: from developmental regulator to cancer therapeutic target |
| Q38658528 | The roles of microRNAs in Wilms' tumors |
| Q35173260 | The yin and yang of kidney development and Wilms' tumors |
| Q37234148 | Transgenic expression of microRNA-185 causes a developmental arrest of T cells by targeting multiple genes including Mzb1. |
| Q38066406 | While at Rome miRNA and TRAIL do whatever BCR-ABL commands to do. |
| Q58763916 | ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting |
| Q35677296 | miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop |
| Q33597730 | miR-185 enhances the inhibition of proliferation and migration induced by ionizing radiation in melanoma |
| Q39041981 | miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer |
| Q39376552 | miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms |
| Q49729843 | miR-204-5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expression. |
| Q64107786 | miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo |
| Q37229470 | miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2 |
| Q64099326 | miR‑185‑5p targets ROCK2 and inhibits cell migration and invasion of hepatocellular carcinoma |
| Q34269240 | microRNA expression and biogenesis in cellular response to ionizing radiation |
Search more.